IMBCR

About the Institute for Myeloma and Bone Cancer Research

The Institute for Myeloma and Bone Cancer Research (IMBCR) was established in 2003 by Dr. James R. Berenson, a pioneer in multiple myeloma research. Located in the heart of cancer research, IMBCR is dedicated to advancing treatment through scientific innovation and personalized patient care.

Impact of Our Research

IMBCR's groundbreaking research has led to new treatments for multiple myeloma, significantly improving patient care and extending life expectancy. By enabling faster disease identification and optimized treatment plans, the organization aims to eradicate myeloma and enhance patients' quality of life.

Why Donate?

Your donation to IMBCR supports life-saving research focused on finding better treatments and ultimately a cure for multiple myeloma. Contributions help reimagine drug development strategies and provide personalized care to maximize treatment benefits.

Join the Fight Against Myeloma

Support the Institute for Myeloma and Bone Cancer Research today! Your generous contributions, whether in cryptocurrency or cash, can make a significant difference in the lives of patients battling myeloma. Together, we can advance research and improve patient outcomes.